Stock Markets: Nasdaq

Catalyst Biosciences Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Dec. 19, 2017 -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications (the Company), today announced that it is offering, subject to market conditions, shares of its common stock in an underwritten public offering. The Company anticipates using the net proceeds from this offering for general corporate purposes, which may include clinical trials, research and development...

Published on .

Capital Southwest Supports the Growth of Clickbooth, a Centre Lane Partners Portfolio Company

DALLAS, Dec. 19, 2017 -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq:CSWC), a middle-market lending firm focused on supporting the acquisition and growth of middle market businesses, announced today that it has completed an investment in Clickbooth.com, LLC (“Clickbooth”), a portfolio company of Centre Lane Partners (“Centre Lane”). The investment is a first lien term loan and revolving credit facility utilized to support the company’s growth initiatives. Capital Southwest...

Published on .

Liberty Tax Service Receives Notice of Delinquent Filing

VIRGINIA BEACH, Va., Dec. 19, 2017 -- Liberty Tax, Inc. (NASDAQ:TAX), the parent company of Liberty Tax Service, announced today that, as a result of its failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2017 (the “Form 10-Q”), it has received a notice from Nasdaq that the Company is not in compliance with Nasdaq’s continued listing rules under the timely filing criteria established under Nasdaq Listing Rule 5250(c)(1) of the Nasdaq...

Published on .

ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer

DOYLESTOWN, Pa., Dec. 19, 2017 -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (“ProPhase”), announced today the preliminary results of its tender offer to purchase up to 1,700,000 shares of its common stock at a price of $2.30 per share, which expired at midnight, New York City time, on December 18, 2017.Based on the preliminary count by American Stock Transfer & Trust Company, the Depositary for the tender offer, an aggregate...

Published on .

Nexeo Solutions Reprices Term Loan Credit Facility

THE WOODLANDS, Texas, Dec. 19, 2017 -- Nexeo Solutions, Inc. (NASDAQ:NXEO) (“Company”), a leader in chemicals and plastics distribution, announced today, through its wholly owned subsidiaries, that it has entered into an Amendment to its Term Loan Credit Facility (the “Amendment”).The Amendment reflects a 50 basis points reduction in the interest rate to LIBOR plus 3.25% from LIBOR plus 3.75% and provides a prepayment premium equal to 1% of the amount of the term loan applicable to certain...

Published on .

Biogen and Ionis Enter into New Collaboration to Identify Novel Therapies for the Treatment of Spinal Muscular Atrophy

CAMBRIDGE, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that they have entered into a new collaboration agreement to identify new antisense oligonucleotide drug candidates for the treatment of spinal muscular atrophy (SMA). Biogen will have the option to license therapies arising out of this collaboration and will be responsible for their development and commercialization. “We are pleased to extend our collaboration...

Published on .

IBERIABANK Corporation Provides 2018 Financial Guidance

LAFAYETTE, La., Dec. 19, 2017 -- IBERIABANK Corporation (NASDAQ: IBKC), holding company of the 130-year-old IBERIABANK (www.iberiabank.com), announced financial guidance for expected full-year 2018 results. Daryl G. Byrd, President and Chief Executive Officer, commented, "As we prepare for a new year, we are refining key strategies to take advantage of our greatest opportunities. We remain committed to attracting and retaining exceptional clients and making changes necessary to continue...

Published on .

ALJ Regional Holdings, Inc. Announces Earnings For The Fourth Quarter And Year Ended September 30, 2017

NEW YORK, Dec. 19, 2017 -- ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) ("ALJ") announced results today for its fourth quarter and year ended September 30, 2017.  ALJ is a holding company, whose primary assets are its subsidiaries Faneuil, Inc. (including the customer management outsourcing business recently acquired from Vertex Business Services LLC, "Faneuil"), Floors-N-More, LLC, dba Carpets N' More ("Carpets"), and Phoenix Color Corp. (including the recently acquired Color Optics...

Published on .

Camden National Corporation Announces a 9% Increase in its Fourth Quarter 2017 Dividend; Provides Initial Estimate of Tax Bill Impact

CAMDEN, Maine, Dec. 19, 2017 -- Gregory A. Dufour, president and chief executive officer of Camden National Corporation (NASDAQ®: CAC; the "Company") announced today that the board of directors of the Company increased its fourth quarter 2017 dividend by $0.02 per share, or 9%, to $0.25 per share. The dividend is payable on January 31, 2018 to shareholders of record on January 15, 2018. "Our strong financial performance has resulted in a solid capital base which allows for a 9% increase in...

Published on .

Casa Systems Announces Closing of Initial Public Offering

ANDOVER, Mass., Dec. 19, 2017 -- Casa Systems, Inc. (NASDAQ:CASA), a provider of software-centric solutions for next-generation distributed and virtualized architectures in cable operator, fixed telecom and wireless networks, today announced the closing of its initial public offering of 6,900,000 shares of its common stock at a public offering price of $13.00 per share, including 900,000 additional shares of common stock issued upon the exercise in full by the underwriters of their over-allotment...

Published on .

HomeStreet Bank Signs Five-Year Renewal for LoanSphere MSP Servicing System; Implements LoanSphere Invoicing Solution

Agreement continues nearly 45-year relationship with Black KnightHomeStreet Bank signed a five-year renewal for LoanSphere MSP to support its servicing business.HomeStreet Bank also went live on LoanSphere Invoicing, a web-based invoice management solution that automates the default billing and invoice process.HomeStreet Bank is one of Black Knight’s longest-standing clients.JACKSONVILLE, Fla., Dec. 19, 2017 -- Black Knight, Inc. (NYSE:BKI) announced today that HomeStreet Bank, a mortgage banking...

Published on .

Synthesis Energy Systems, Inc. Regains Nasdaq Compliance

HOUSTON, Dec. 19, 2017 -- Synthesis Energy Systems, Inc. (SES) (NASDAQ:SES), a global leader in the clean and efficient production of low-cost synthesis gas for high value energy and chemical products, today announced that it has received notification from The Nasdaq Stock Market that it has regained compliance with Listing Rule 5550(a)(2) to maintain the listing of its common stock on the Nasdaq Capital Market.  About Synthesis Energy Systems, Inc.Synthesis Energy Systems (SES) is a Houston-based...

Published on .

Galectin Therapeutics Announces $10 Million Credit Line from Richard E. Uihlein Sufficient to Cover Expected Expenditures Into 2019

NORCROSS, Ga., Dec. 19, 2017 -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced it entered into a $10 million unsecured line of credit facility with stockholder and new director Richard E. Uihlein.“I have been a shareholder and supporter of Galectin Therapeutics for many years, and I am very encouraged by the Company’s positive efficacy results in its NASH-CX trial for patients with cirrhosis due to NASH.  ...

Published on .

Five Prime Therapeutics and Zai Lab Announce Exclusive License Agreement for FPA144 Anti-FGFR2b Antibody in Greater China and Global Strategic Development Collaboration

SOUTH SAN FRANCISCO, Calif. and SHANGHAI, China, Dec. 19, 2017 -- Five Prime Therapeutics, Inc. (NASDAQ:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, and Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced an exclusive license agreement for FPA144 in Greater China and global strategic development collaboration. Five Prime’s FPA144 is a first-in-class isoform-selective, humanized...

Published on .